FDA Carves Out Broad Powers In Drug Inspections

Law360, New York (July 22, 2013, 5:25 PM EDT) -- The U.S. Food and Drug Administration is asserting broad investigative powers in new guidance describing how it polices drugmakers, claiming wide authority to seize shoddy products if a manufacturer tries to impede inspectors and making its boldest declaration yet that inspectors can snap photographs that are critical to proving cases, lawyers say.

In draft guidance earlier this month, the FDA specifically described numerous hypothetical examples of manufacturers delaying or obstructing inspectors, which could lead to products being confiscated and deemed unfit for sale. However, those examples...
To view the full article, register now.